Pet imaging for gene & cell therapy

Sara A. Collins, Kei Hiraoka, Akihito Inagaki, Noriyuki Kasahara, Mark Tangney

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

As the interest in gene therapy increases, the development of an efficient and reliable means to monitor gene delivery and expression in patients is becoming more important. An ideal imaging modality would be non-invasive, allowing for repeated imaging, thus validating stages subsequent to vector administration and allowing for the improvement of clinical protocols. Positron Emission Tomography (PET) has been employed for some time in clinical imaging and has in more recent years been adapted to enable imaging in small animal models, including gene therapy models for a range of diseases. PET imaging is based on the detection of trace quantities of positron-emitting molecular probe within cells post-administration, permitting imaging of target molecules in vivo, and numerous tracers have been developed for a wide range of applications, including imaging of reporter gene activity. Use of radiolabelled substrates that interact with specific transgene proteins, has identified a number of reporter genes that are suitable for imaging vector mediated gene delivery and expression in both pre-clinical and clinical situations. These reporter genes enable non-invasive analysis of the location, level and kinetics of transgene activity. Among the various imaging modalities in existence, the PET approach displays arguably the optimum characteristics in terms of sensitivity and quantitation for in vivo gene expression measurements. Given the existing availability of PET scanning equipment and expertise in hospitals, this imaging modality represents the most clinically applicable means of analysing gene therapy in patients. This review outlines the principles of PET imaging in the context of gene and cell therapy at both pre-clinical and clinical levels, comparing PET with other relevant modalities, and describes the progress to date in this field.

Original languageEnglish (US)
Pages (from-to)20-32
Number of pages13
JournalCurrent Gene Therapy
Volume12
Issue number1
StatePublished - Feb 1 2012

    Fingerprint

Keywords

  • Cancer
  • Clinical imaging
  • HSV-TK
  • Molecular imaging
  • Nuclear medicine
  • Positron emission tomography
  • Reporter
  • Vector

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Drug Discovery
  • Genetics(clinical)

Cite this

Collins, S. A., Hiraoka, K., Inagaki, A., Kasahara, N., & Tangney, M. (2012). Pet imaging for gene & cell therapy. Current Gene Therapy, 12(1), 20-32.